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Malodorous consequences:
What comprises negligence in anosmia litigation?
Peter F. Svider, MD1, Andrew C. Mauro, BA2, Jean Anderson Eloy, MD, FACS3,4,5, Michael Setzen,
MD, FACS6, Michael A. Carron, MD1 and Adam J. Folbe, MD1
Background: Our objectives were to evaluate factors
raised in malpractice litigation in which plaintiﬀs alleged
that physician negligence led to olfactory dysfunction.
Methods: We analyzed publically available federal and
court records using Westlaw, a widely used computerized
legal database. Pertinent jury verdicts and selements
were comprehensively examined for alleged causes of mal-
practice (including procedures for iatrogenic causes), de-
fendant specialty, patient demographics, and other factors
raised in legal proceedings.
Results: Of 25 malpractice proceedings meeting inclusion
criteria, 60.0% were resolved for the defendant, 12.0%
were seled, and 28.0% had jury-awarded damages. Me-
dian payments were signiﬁcant ($300,000 and $412,500 for
selements and awards, respectively). Otolaryngologists
were the most frequently named defendants (68.0%), with
the majority of iatrogenic cases (55.0%) related to rhino-
logic procedures. Associatedmedical events accompanying
anosmia included dysgeusia, cerebrospinal ﬂuid leaks, and
meningitis. Other alleged factors included requiring addi-
tional surgery (80.0%), unnecessary procedures (47.4% of
iatrogenic procedural cases), untimely diagnosis leading to
anosmia (44.0%), inadequate informed consent (35.0%),
dysgeusia (56.0%), and psychological sequelae (24.0%).
Conclusion: Olfactory dysfunction can adversely aﬀect
quality of life and thus is a potential area for malpractice
litigation. This is particularly true for iatrogenic causes of
anosmia, especially following rhinologic procedures. Set-
tlements and damages awarded were considerable, mak-
ing an understanding of factors detailed in this analysis of
paramount importance for the practicing otolaryngologist.
This analysis reinforces the importance of explicitly includ-
ing anosmia in a comprehensive informed consent process
for any rhinologic procedure. C© 2013 ARS-AAOA, LLC.
KeyWords:
anosmia; hyposmia; malpractice; litigation; negligence; rhi-
nology; rhinologic; informed consent
How to Cite this Article:
Svider PF, Mauro AC, Eloy JA, Setzen M, Carron MA,
FolbeAJ.Malodorous consequences:what comprises neg-
ligence in anosmia litigation? Int Forum Allergy Rhinol.
2014;4:216–222.
1Department of Otolaryngology–Head and Neck Surgery, Wayne State
University School of Medicine, Detroit, MI; 2, The University of Michigan
Law School, Ann Arbor, MI; 3Department of Otolaryngology–Head and
Neck Surgery, Rutgers New Jersey Medical School, Newark, NJ;
4Department of Neurological Surgery, Rutgers New Jersey Medical
School, Newark, NJ; 5Center for Skull Base and Pituitary Surgery,
Neurological Institute of New Jersey, Rutgers New Jersey Medical
School, Newark, NJ; 6Rhinology Section, North Shore University
Hospital, Manhasset, NY
Correspondence to: Peter F. Svider, MD, Department of
Otolaryngology–Head and Neck Surgery, Wayne State University School of
Medicine, 4201 St. Antoine, 5E-UHC, Detroit, MI 48201; e-mail:
psvider@gmail.com
Potential conflict of interest: M.S. is a speaker for TEVA and MEDA on their
Speakers Bureau.
Received: 15 August 2013; Revised: 10 October 2013; Accepted:
31 October 2013
DOI: 10.1002/alr.21257
View this article online at wileyonlinelibrary.com.
R ecent investigation has revealed a potential for olfac-tory epithelium to regenerate via a variety of mech-
anisms involving a population of mesenchymal-like stem
cells, which have been shown to have a surprisingly broad
anatomic distribution.1 Whereas stem cell–based therapy
and other contemporary advances in our understanding of
olfaction offer promising future avenues for anosmia man-
agement, our current therapeutic repertoire for restoring
smell in patients remains limited. Olfactory deficits consid-
erably affect quality of life and may even facilitate adverse
health events, ranging from inability to sense environmental
cues (such as leaking natural gas, spoiled food) to unsafe
losses in weight.2–4 Additionally, olfactory function is a
critical component of being able to taste, and true anosmia
is thus frequently accompanied by dysgeusia.5
The profound effects on both health status and quality
of life present in patients with olfactory deficits predispose
negative outcomes to potential involvement in medicolegal
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action. Given the outsize role malpractice litigation and re-
sulting defensive medical practices play in rising healthcare
costs,6–11 understanding potential sources of medical neg-
ligence and iatrogenic injury resulting in anosmia may be
useful for the practicing physician. In addition to delineat-
ing procedures causing anosmia and resulting in litigation,
the objectives of this analysis were to determine alleged
causes of negligence in pertinent litigation, case outcomes
and awards, and medical specialties affected. Our hope is
that physicians will use this information to enhance com-
munication with patients and, ultimately, improve patient
safety.
Materials and methods
A computerized legal database, Westlaw, was used to ob-
tain information regarding pertinent cases for the purposes
of this analysis. Westlaw is available by subscription and
widely used by legal professionals in the United States, and
has been invaluable in previous comprehensive examina-
tions of a wide variety of medicolegal topics.11–38 This
database’s advanced search function was used to search for
jury verdicts and settlements containing the following com-
bination of terms: “medical malpractice” AND “anosmia”
OR “hyposmia” OR “smell” OR “olfaction” OR “olfac-
tory.” Out of 49 initial results, cases were excluded for the
following reasons: incidental mention of anosmia (ie, anos-
mia not an alleged injury in litigation) (7), duplicate cases
(2), cases that did not involve anosmia or olfactory deficits
(14), and congenital anosmia (1).
The 25 pertinent jury verdict and settlement reports with
anosmia as an alleged injury were comprehensively eval-
uated for details regarding outcome, award, defendant
specialty, patient demographics, iatrogenic or noniatro-
genic cause, procedures involved, allegations involving in-
complete informed consent, the requirement of reparative
procedures, misdiagnosis/delayed diagnosis leading to in-
jury, dysgeusia, psychiatric/psychological sequelae, depres-
sion/loss of enjoyment in life, employment/income affected,
and other alleged causes of negligence. Data collection was
completed in August 2013.
Statistical analysis
Mann-Whitney U-tests were used for comparison of con-
tinuous data, with threshold for significance set at p< 0.05.
SPSS version 20 (IBM, Chicago, IL) was used for statistical
analysis.
Results
The 25 jury verdict and settlement reports containing anos-
mia occurred between 1989 and 2011. Median patient age
was 54 years, with 52.2%male plaintiffs and 47.8% female
plaintiffs. The majority of cases included were resolved in
the defendant’s favor (60.0%), with remaining cases re-
solved as out-of-court settlements or with plaintiff verdicts
(Fig. 1A). Although considerably large, the median dam-
ages awarded by juries did not significantly differ from the
2 out-of-court settlements reporting dollar totals (Fig. 1A)
($300,000 vs $412,500, p > 0.50). Otolaryngologists were
the most frequently named physician defendants (68.0% of
cases), followed by oral surgeons (Table 1). Practitioners
from several other specialties were also named as defen-
dants (Table 1).
The most frequent procedure performed leading to anos-
mia litigation was endoscopic sinus surgery (ESS) (7 pro-
cedures; Table 2), followed by a variety of other proce-
dures performed by otolaryngologists and oral surgeons.
Associated medical adverse events allegedly accompany-
ing anosmia included dysgeusia, cerebrospinal fluid (CSF)
leaks, and meningitis (Fig. 1B). Other alleged factors in-
volved in litigation included anosmia being a result of ia-
trogenic causes (80.0% of all cases), additional surgery be-
ing required as a result of an adverse outcome (80.0% of
all cases), and a procedure being allegedly unnecessary or
inappropriate (9/19 iatrogenic procedural cases); other al-
leged factors are also shown in Figure 1C. Out of the 20
iatrogenic cases, 19 were related to surgical procedures and
1 was related to medication administration. Specific fac-
tors involved in cases resolved with payment are shown in
Table 3.
Discussion
Although there have been no formal analyses of anosmia
litigation, the possibility of medicolegal action in patients
experiencing this complication after undergoing a surgi-
cal procedure has been anecdotally reported. In a letter
to a journal, 1 otolaryngologist noted hearing of several
rhinologic cases in which plaintiffs exploring legal action
claimed they had not been informed of anosmia as a po-
tential complication.39 This report was consistent with a
survey he had conducted, in which fewer than 50% of oto-
laryngologists included anosmia in the informed consent
process as a potential complication of nasal surgery. Our
present analysis reinforces previously described anecdotal
findings for the first time, as plaintiffs specifically brought
up inadequate informed consent in a significant proportion
of iatrogenic cases (35.0%) (Fig. 1C). Perceived deficits in
informed consent have been repeatedly cited in a significant
proportion of analyses focusing on various procedures and
complications.14,16,24,33,34 Rather than physicians notmen-
tioning the possibility of olfactory dysfunction, a significant
proportion of these cases may simply relate to patients not
comprehending risks explained to them. In addition to doc-
umenting specific risks in writing, physicians performing
procedures that may potentially result in anosmia may wish
to consider providing patient education materials written
in a comprehendible manner.40–51
In addition to informed consent, several other pre-
viously described considerations were also identified as
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FIGURE 1. (A) Outcome profile of cases included in this analysis, with median and range of settlements and jury awards (in $1000s). (B) Associated alleged
medical adverse events in cases involving alleged anosmia. (C) Alleged factors present in litigation included in this analysis. Results in B and C are illustrated
as a percentage of pertinent cases; for example, UP is out of cases involving procedures (19 cases), Iatr is out of all cases. Addt’l = patient required additional
surgery as a result of an adverse outcome experience; Consort = loss of consortium; CSF = cerebrospinal fluid leak; Def. = defendant decision; Depress =
depression/emotional distress; FtDx = failure to diagnosis cancer; Iatr = iatrogenic; IC = alleged deficit in informed consent; Men = meningitis; Mis/Delay =
failure to diagnosis a complication in a timely manner; NPS = nasopharyngeal stenosis; Plaint. = plaintiff verdict; Psych = permanent psychiatric/psychological
effects; Settle = out-of-court settlement; Taste = dysgeusia; UP = allegedly unnecessary/inappropriate procedure choice; Work = work/employment allegedly
affected by injury.
TABLE 1. Defendant specialty in cases with alleged
anosmia
Specialty Cases, n (%)
Otolaryngology 17 (68.0)
Oral surgery 3 (12.0)
Pathology 1 (4.0)
Neurosurgery 1 (4.0)
Primary care 1 (4.0)
Plastic surgery 1 (4.0)
Psychiatry 1 (4.0)
Radiology 1 (4.0)
recurrent factors in the present analysis. In a previous eval-
uation of malpractice trials with alleged iatrogenic cra-
nial nerve injuries, the authors found a successive decrease
in defendant verdict percentages with the presence of an
increasing number of the following factors: (1) informed
TABLE 2. Procedures/conditions involved in litigation
Procedure/condition Cases (n)
Endoscopic sinus surgery 7
Septorhinoplasty 3
Laryngectomy 2
Adenotonsillectomy 2
Delayed Dx of tumor 2
Voice prosthesis implant 1
Medication-induced 1
Maxillectomy 1
Mandibular/maxillary osteotomy 1
Failed suicide attempt 1
CN V nerve decompression 1
Dental procedure 1
CN = cranial nerve; Dx = diagnosis.
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TABLE 3. Characteristics of cases resolved with payment
A/S O Award Def Procedure Alleged deficit in IC UP Taste Other injuries/comments
60M P 55 NS CNV decomp. Y N Y Primary claim that IC did
not include anosmia
M P 102 OS Bridge N N Y Dental polymeric material
retained in sinus
30F P 200 Oto Septo/rhino N N N Cribriform plate CSF leak,
meningitis
42M P 300 Oto ESS N Y Y Olfactory nerves directly
damaged, frontal lobe
injury, CSF leak,
meningitis, cognitive
impairment
63F P 925 PCP Medication Y N/A N Methadone OD, cognitive
impairment
33F P 1900 Oto ESS N Y Y Perforated ethmoid sinus,
CSF leak, facial
paralysis
72M P 2000 Oto Laryngectomy N Y N Found no cancer on
surgery (postradiation);
surgery unnecessary
S 250 Oto T&A N N N Nasopharyngeal stenosis
57M S 575 Oto ESS N N N CSF leak, meningitis,
“mild” brain damage
F S Conf. Psych Failed SA N/A N/A Y Failed attempt by hanging;
anosmia 1 of several
alleged injuries due to
ABI
Awards are shown in $1000s.
ABI = anoxic brain injury; A/S O = age/sex of plaintiff and outcome; CSF = cerebrospinal fluid; CNV = cranial nerve V; CNV decomp. = trigeminal nerve decompression;
Conf = confidential; ESS = endoscopic sinus surgery; Def = defendant specialty; Failed SA = failed suicide attempt; IC = informed consent; N/A = not applicable; NS
= neurosurgery; OD = overdose; OS = oral surgery; Oto = otolaryngologist; P = plaintiff decision; PCP = primary care provider; Psych = psychiatrist; S = settlement;
Septo/rhino = septorhinoplasty; T&A = adenotonsillectomy; Taste = taste affected (dysgeusia); UP = allegedly unnecessary or inappropriate procedure.
consent allegations; (2) allegedly unnecessary procedures;
(3) additional reparative surgery required; and (4) fail-
ure to diagnose a complication in a timely manner.16 As
these general principles appear to be consistent across nu-
merous topics, this highlights the importance of consid-
ering an out-of-court settlement in cases where several of
these factors are present. Although there was no statisti-
cal difference between the size of jury-awarded damages
and out-of-court settlements in the current analysis, there
are considerably greater costs associated with cases that
advance all the way to the courtroom for both sides. In
fact, a larger proportion of legal expenditures are related
to these “indirect” costs rather than the costs of damages
awarded.52 Additionally, costs associated with malpractice
litigation also involve the significant proportion of time a
physician may expend on proceedings in their career, esti-
mated by 1 analysis to encompass as much as 5 years with
an open claim for the average physician.7 Another indirect
effect includes a concern about the impact that involve-
ment in litigation may have on one’s reputation, among
both patients and colleagues.10,53 Finally, the current medi-
colegal environment facilitates the practice of defensive
medicine. All of these factors, along with sizeable malprac-
tice insurance premiums, increase healthcare costs in the
United States by as much as tens of billions of dollars each
year.6,9,12,35,54–58
It is important to remember that in order for negligence
to be proven, the occurrence of an adverse event alone is
not grounds for awarding damages. Other factors must in-
clude the presence of a duty, a breach of this duty, and
evidence that this breach of duty was directly responsible
for causing a harmful event.12,19,59 The severity of injuries
other than anosmia along with a number of oversights po-
tentially construed as negligence appeared to play a role in
the size of damages awarded by juries (Table 3). Several in-
teresting lessons can be gathered from these specific cases.
For example, the rhinologic case with the highest damages
award resulted in a $1.9M award (Table 3). In this case,
the defendant otolaryngologist allegedly failed to diagnose
a postoperative CSF leak, which was eventually picked up
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by the plaintiff’s primary care doctor. The plaintiff’s skull-
base defect was deemed not to be amenable to endoscopic
management, thus necessitating a craniotomy to repair
the leak. In addition to convincing the jury that another
otolaryngologist in a similar scenario would have been
reasonably more vigilant and would have recognized a
CSF leak sooner, the plaintiff alleged that the defendant
otolaryngologist failed to pursue conservative treatment
with antibiotics and other medications prior to surgery,
thus making the ESS not indicated. The size of this judg-
ment was furthermore influenced by permanent deficits
from both the initial and reparative procedures, includ-
ing anosmia and dysgeusia, along with an alleged facial
paralysis.
The three ESS cases with anosmia in this analysis that
were resolved with a settlement or jury-awarded damages
had a median payment of $575,000 (range, $300,000-
$1.9M) (Table 3); these cases were resolved in the years
1999 to 2002. The authors have recently examined ESS lit-
igation dating from 2003 to the present,30 and we retrieved
our source data from that analysis and compared payments
in iatrogenic ESS cases (none of which involved anosmia),
which had a median of $905,000 (range, $89,000-$3.9M).
This comparison was not statistically significant (p= 0.67),
demonstrating that the presence or absence of anosmia
may not have an obvious effect on the amount of damages
awarded, although this is speculative due to the multitude
of factors that may be present in all of these cases and which
may play a role in compensation totals.
Although plaintiffs initiated litigation in several cases
in which a failure to diagnose cancer in a timely manner
played a role in the development of anosmia (either through
delayed treatment or the cancer itself) (Tables 2 and 3), 1 of
these cases is an effective example of the plaintiff failing to
prove all of the factors required for a finding of negligence.
A patient had seen his dentist several times a year over sev-
eral years for periodontal cleaning, and on 1 visit a small
lip lesion was excised and found to be adenoid cystic carci-
noma. The plaintiff alleged that a delay in diagnosis neces-
sitated radiation therapy, which subsequently led to a loss
of smell and taste. The defendant argued that perineural
invasion, for which this disease process is known,60 likely
started the moment the cancer started to grow, and most
importantly, that a delay in treatment resulted in no differ-
ence in the treatment received. Even if the dentist should
have detected the lesion earlier, his legal team was able to
demonstrate to the jury that this would not have made a
difference in the patient’s management (and thus on ra-
diation side effects such as anosmia); thus this potential
“breach of duty” was not directly responsible for causing
any additional harm to the patient, an essential component
of attributing negligence.59
One case of interest resolved with an out-of-court set-
tlement (Table 3) involved complications stemming from
an adenotonsillectomy for chronic hypertrophic adenoidi-
tis, tonsillitis, and sleep apnea. The adult plaintiff alleged
that the defendant otolaryngologist removed excessive tis-
sue during surgery that resulted in “excessive scarring and
obstruction of the nasal airway.” He claimed the “reduc-
tion in the ability to smell” contributed to a “diminished
ability . . . to enjoy life.” No other major injuries were al-
leged by the plaintiff in this particular case, and it appears
that anosmia played a primary role in the defendant’s deci-
sion to pursue an out-of-court settlement.
We have previously evaluated CSF leaks and their im-
pact on malpractice litigation,37 noting that approximately
one-fifth of cases in this previous analysis involved anos-
mia. Damages awarded and out-of-court settlements were
found to be considerably higher in that analysis ($1.1M and
$966,887, respectively) than those calculated in our current
analysis ($300,000 and $412,500, respectively), possibly a
result of the higher coincidence of intracranial complica-
tions associated with patients experiencing iatrogenic CSF
leaks.
None of these cases in which plaintiffs attributed anos-
mia as a result of medical negligence explicitly mentioned
the use of objective testing in an attempt to confirm this
complaint. We would be remiss not to emphasize the avail-
ability of a variety of tools that may be useful in objectively
characterizing and confirming the presence of anosmia, in-
cluding the San Diego Odor Identification Test and the
University of Pennsylvania Smell Identification Test.61 For
example, the latter test is based on a 40-point scale and
can likely identify many malingerers,62 which may be an
important point in malpractice litigation.
The present analysis is the first to comprehensively search
for and evaluate litigation in which plaintiffs allege anosmia
as a result of medical negligence. Despite its potential value
in educating physicians about the types of cases and out-
comes resulting from these proceedings, there are several
limitations inherent to an analysis of this nature. Westlaw
is a highly used resource among legal professionals and
has shown its value in a multitude of previous medicolegal
analyses,11–35,37 but this resource is focused on jury ver-
dicts and settlements that advance far enough in proceed-
ings for inclusion into publically available court records.
A number of out-of-court settlements may not proceed far
enough for inclusion into these records, stressing the point
that this resource is far more valuable for its rich detail and
discussion of specific factors brought up in litigation than
as a tool to estimate the overall prevalence of an injury
leading to legal action. While some jury verdict and set-
tlement reports from some jurisdictions are composed of
attorney-submitted cases,15,17 many jurisdictions also con-
tain involuntarily submitted information; confidential cases
from these places are labeled as “confidential,” “John/Jane
Doe,” or “anonymous.”
Another potential limitation of this analysis is relevant
in the study of malpractice proceedings from any resource:
factors affecting the quality of legal representation for de-
fendants and plaintiffs may not be apparent through court
records and may play a role in the success of malprac-
tice proceedings. For example, qualitative differences in
medical expert witness testimony have been noted among
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neurological surgery and otolaryngology proceedings, in
which defendant witnesses tend to be more experienced,
have higher scholarly impact, and are more likely to be
involved in academic practice.21,22,26 On the other hand,
these analyses suggest those testifying frequently or repeat-
edly tend to be testifying on behalf of plaintiffs. While it is
not entirely clear what effects these phenomena and other
differences in legal representation have on outcomes, it is
definitely an issue to keep inmindwhen trying to discern the
differences between cases that may be resolved with pay-
ment vs those resolved in a defendants favor. This discus-
sion regarding expert witness qualification is purely specu-
lative in the context of this analysis because these statistics
were not examined and would have been unlikely to pro-
vide any reliable conclusions, as there were only 25 cases
meeting inclusion criteria in the current analysis.
A final limitation is the heterogeneous nature of these
cases, specifically relating to the fact that the presence of
anosmia may have had varying importance depending on
other associated injuries. It may often times be difficult to
tease apart the importance of specific injuries when nu-
merous injuries are present, but we feel we have accom-
plished our objectives of relaying the types of cases in which
anosmia may be a factor, and which procedures necessi-
tate a comprehensive informed consent process including
anosmia.
Conclusions
As olfactory dysfunction can have a significant impact on
quality of life, patients experiencing new-onset anosmia as
a result of medical care pursuemalpractice litigation. This is
particularly true for iatrogenic cases, including those stem-
ming from rhinologic procedures. Cases resolved with pay-
ment were considerable, with the median damages awarded
by a jury totaling $300,000. Consequently, an understand-
ing of factors critical in initiating litigation is of paramount
importance for the practicing otolaryngologist. Other asso-
ciated injuries frequently experienced in these cases, such
as dysgeusia, CSF leaks and meningitis, and psychologi-
cal effects, should be taken into account. Requiring addi-
tional surgery, having undergone an allegedly unnecessary
procedure, missed/delay diagnosis leading to anosmia, and
perceived deficits in informed consent were present in a
significant proportion of cases. Finally, this analysis rein-
forces the importance of explicitly including anosmia in a
comprehensive informed consent process for any rhinologic
procedure.
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